Ad Code: Dato DX-d - NACLC Display Banners Conference - Jan - 92410

Social determinants of health influenced the achievement of textbook oncological outcomes and overall survival in non-small cell lung cancer.

Lymphovascular invasion is an independent predictor for shorter recurrence-free survival for patients with stage I NSCLC.

Dr. Reckamp co-authored a paper that addresses the need for cautious progression from phase 1 to phase 3 trials for advanced NSCLC, summarized here.

At 2023 NACLC, Heather Law, MA, presented a recap of “Associations of HRQOL with daily functioning/communication with care teams in patients with ALK+ NSCLC.”

At 2023 NACLC, Xiaohan Hu presented “Real-World Patients Characteristics, Biomarker Testing & Adjuvant Therapy for Resected NSCLC at US Oncology Clinics, 2019-2023”

At the 2023 NACLC, Benjamin Lok, MD, FRCPC, presented a radiation “mini-debate” focused on the “Goldie Locks Effect.”

At the 2023 NACLC, Florian Fintelman, MD, presented a recap of data on the use of artificial intelligence for lung cancer risk prediction on chest CT.

Forget the O’Hare food kiosks and grab lunch at one of these locations instead, all within easy walking distance from the Chicago Marriott Downtown Magnificent Mile

Don’t miss the 2023 NACLC closing keynote—Perioperative Therapy—to be given by Jonathan Spicer, MD, PhD, 11:15 a.m.-12:15 p.m., Sunday, December 3, 2023.

Make the most of your final day at the 2023 NACLC conference—use the program information below to plan your schedule:

2023 NACLC is taking place in Chicago’s famous “Magnificent Mile” district, so be sure to set aside a little time for exploring!

Check out the fascinating array of topics to be covered during 2023 NACLC satellite CME symposia!

The IASLC 2023 North America Conference on Lung Cancer (NACLC) runs December 1-3, 2023, at the...